3M Company

NYSE:MMM 株式レポート

時価総額：US$93.9b

3M 将来の成長

Future 基準チェック /26

3M利益と収益がそれぞれ年間12.1%と3.2%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に74% 13.9%なると予測されています。

主要情報

12.1%

収益成長率

13.90%

EPS成長率

Industrials 収益成長11.3%
収益成長率3.2%
将来の株主資本利益率74.02%
アナリストカバレッジ

Good

最終更新日10 Aug 2026

今後の成長に関する最新情報

Recent updates

ナラティブ更新 • Aug 03

MMM: Q2 Execution And AI Ties Will Test PFAS Legal Overhang

The analyst price target for 3M has shifted higher in recent weeks, with the updated fair value estimate moving from about $171 to roughly $182, as analysts cite stronger Q2 earnings, improved organic growth and productivity, and a more confident multi year outlook for the company's product pipeline. Analyst Commentary Recent research on 3M shows a wide range of views on the stock, even as many analysts lift their price targets following the Q2 report and updated guidance.
Seeking Alpha • Jul 21

3M: The Turnaround Is Real, But Already Priced In

Summary 3M Company remains a Hold as valuation reached its fair value, even when taking into account the strong Q2 performance and guidance boost. 3M delivered 5.4% sales growth, 12% EPS growth in H1, and raised 2026 EPS guidance to $8.80–$8.95. Litigation liabilities and macro/geopolitical risks continue to weigh on 3M's risk-reward profile. AI/data center exposure and portfolio optimization offer long-term growth, but current risk-reward is unattractive. Read the full article on Seeking Alpha
ナラティブ更新 • Jul 20

MMM: PFAS Lawsuits Will Continue To Cap Upside Despite Improving Demand

Analysts have adjusted their fair value estimate for 3M slightly lower to about $121.62. This reflects a modestly higher discount rate alongside marginally stronger assumptions for revenue growth, profit margins, and a lower future P/E, informed by recent price target changes that highlight both optimism around improving industrial demand and ongoing concerns about execution and legacy risks.
ナラティブ更新 • Jul 06

MMM: Transformation And Legal Progress Will Support Future Re Rating

Analysts have trimmed their fair value estimate for 3M from $222.65 to $209.00. This reflects updated assumptions around discount rates, profit margins, and longer running concerns such as persistent PFAS liabilities and questions about the pace of the company's innovation recovery.
ナラティブ更新 • Jun 22

MMM: Future Margin Execution Faces PFAS Legal Risks After Solventum Spin

Analysts have trimmed their price expectations for 3M, with the updated fair value estimate moving from about $175.03 to $170.97, as recent research has highlighted concerns around execution risks in reigniting growth and ongoing PFAS liabilities, even as margin assumptions improved slightly. Analyst Commentary Recent Street research on 3M points to a mixed setup, with analysts split between concerns around execution and liabilities and some recognition that management has pulled meaningful levers through the ongoing transformation and portfolio moves such as the Solventum spin.
ナラティブ更新 • Jun 06

MMM: PFAS Lawsuit And Overhang Will Constrain Future Upside Potential

Analysts have adjusted their view on 3M, with the implied fair value price target moving from about $125.70 to around $127.90. This reflects updated assumptions on revenue growth, profit margins, and future P/E following the Solventum spin and mixed recent price target changes across the Street.
ナラティブ更新 • May 23

MMM: Margin Execution And Cash Returns Will Support Future Re Rating

Analysts have trimmed their 3M price target by about $1, reflecting slightly lower fair value estimates even as updated models factor in a reduced discount rate, modestly higher revenue growth, a small uptick in projected profit margins, and a somewhat lower future P/E assumption. Analyst Commentary Recent Street research around 3M and its healthcare spin-off Solventum gives you a mixed but generally constructive picture, with attention on how the separation could reshape both companies' earnings profiles and valuation frameworks.
ナラティブ更新 • May 03

MMM: Future Margin Execution And Buybacks Will Support Turnaround Prospects

Analysts have adjusted the 3M price target slightly lower to reflect a new fair value near $175, as recent target cuts from several firms and one smaller increase from Wells Fargo suggest a more cautious view on profit margins, while revenue growth assumptions and future P/E expectations remain steady to slightly higher. Analyst Commentary Recent Street research reflects a more mixed stance on 3M, with several firms trimming price targets and one lifting its target, all clustering around a fair value in the mid US$170s.
ナラティブ更新 • Apr 18

MMM: Execution On Margin Efficiency And Buybacks Will Support Future Re Rating

Analysts have trimmed their 3M fair value estimate by about $2 to $223.59, reflecting slightly lower profit margin assumptions that are only partly balanced by a modestly higher revenue growth outlook and a marginally richer future P/E multiple. Analyst Commentary Recent Street research on 3M reflects a mix of cautious revisions and selective optimism, with several firms adjusting price targets both higher and lower in response to updated assumptions.
ナラティブ更新 • Apr 04

MMM: Operational Discipline And Legal Resolution Will Support Future Re Rating

Analysts have reduced the updated price target on 3M by about $1 to $225.94. This reflects a combination of recent target cuts and increases across firms, along with slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E.
ナラティブ更新 • Mar 21

MMM: Operational Progress And Legal Overhang Resolution Will Support Future Re Rating

The analyst price target for 3M has been adjusted by a few dollars, reflecting mixed but generally constructive updates from recent research. Some firms raised their targets by $2 to $5, while others trimmed theirs by $6 to $8, based on refreshed views of growth, profitability, and valuation assumptions.
ナラティブ更新 • Mar 06

MMM: Digital And Legal Progress Will Support Future Re Rating

The analyst price target for 3M has edged higher by about $1.50, as analysts weighed mixed target moves from major firms alongside slightly updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming their price targets while others raised theirs.
ナラティブ更新 • Feb 20

MMM: Digital Execution And Slightly Higher Fair Value Will Support Re Rating

The analyst price target for 3M has shifted slightly higher, with our fair value estimate moving from $223.00 to about $225.67 as analysts factor in updated growth and margin assumptions, along with mixed target revisions across major firms. Analyst Commentary Recent Street research on 3M shows a split view, with several bullish analysts lifting price targets and others trimming expectations or downgrading the stock.
ナラティブ更新 • Feb 05

MMM: Turnaround Prospects Will Be Tested By PFAS Litigation And Mixed Street Expectations

The analyst price target on 3M has been revised slightly higher to about $177 from $174, as analysts adjust their models for small changes in fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following a mix of recent target increases and cuts across major firms. Analyst Commentary Recent Street research on 3M has been mixed, with several firms adjusting their price targets in both directions and one major downgrade.
ナラティブ更新 • Jan 22

MMM: New Digital Tools And Higher P E Multiple Will Support Re Rating

Analysts have nudged their valuation view on 3M higher, with the updated fair value estimate moving from $212 to $223 as they reassess the stock's longer term earnings power and apply a slightly richer future P/E multiple, despite mixed recent price target changes across the Street. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming targets or ratings and others lifting their valuation marks.
ナラティブ更新 • Jan 07

MMM: Reset Expectations And New Products Will Support Higher Margins

Analysts have raised their fair value estimate for 3M to $212 from $187, citing expectations for higher profit margins, a slightly lower discount rate, and supportive Street research that highlights Q3 execution, new product traction, and reset expectations across multiple firms. Analyst Commentary Recent Street research around 3M clusters around a more constructive setup following Q3, with several bullish analysts revisiting their models on the back of reset expectations, new product traction, and updated legal and macro assumptions.
ナラティブ更新 • Dec 24

MMM: PFAS Litigation Will Ultimately Cap Upside Despite Turnaround Progress

Analysts have raised their price target on 3M, lifting fair value by about $12 per share to roughly $126 as they grow more confident in the company’s improving organic growth, margin expansion, and turnaround initiatives, despite ongoing PFAS litigation risks. Analyst Commentary Recent Street research reflects a more balanced, but still risk aware, view on 3M as estimates reset and execution on the turnaround improves.
ナラティブ更新 • Dec 10

MMM: Turnaround Progress Will Face Ongoing PFAS Litigation And Portfolio Reshaping Risks

Our fair value estimate for 3M has been trimmed slightly to $174.25 from $174.94 as analysts balance higher price targets and improving expectations for new product driven growth and management's turnaround progress against persistent PFAS litigation risk. Analyst Commentary Street research remains divided on 3M, with recent notes highlighting improving execution and product driven growth, offset by continued concern around PFAS liabilities and mixed end market demand.
ナラティブ更新 • Nov 26

MMM: Shares Will Balance Turnaround Progress With Litigation and Asset Sale Uncertainty

Analysts have marginally raised their fair value estimate for 3M to $174.94, citing improved organic growth, ongoing new product introductions, and increased profit margin expectations following recent quarterly results. Analyst Commentary Recent analyst research has revealed a shifting perspective on 3M, as several experts adjust their outlooks based on the company’s latest earnings performance and ongoing strategic initiatives.
ナラティブ更新 • Nov 06

MMM: Shares Will Balance Turnaround Progress With Ongoing Litigation and Portfolio Changes

Analysts have raised their fair value estimate for 3M to $174.31 from $167.81. This change reflects improved organic growth prospects and progress on turnaround initiatives highlighted in recent research updates.
ナラティブ更新 • Oct 22

Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks

3M's fair value estimate has increased by $5.00 to $167.81 as analysts cite modest operating outperformance and positive momentum from new product initiatives, despite some lingering concerns. Analyst Commentary Recent updates from Street research highlight diverging analyst sentiment regarding 3M's valuation trajectory and execution on strategic initiatives.
ナラティブ更新 • Oct 08

New Product Launches And Efficiency Gains Will Boost Future Value

Narrative Update: 3M Analyst Price Target Revision Analysts have increased their price target for 3M to $162.81 from $161.63, citing improved full-year guidance prospects and renewed interest as a short-term buy idea. Analyst Commentary Recent commentary from Street research highlights both optimistic and cautious stances regarding 3M’s near-term prospects.
Seeking Alpha • Mar 11

3M: Multiple Expansion Amidst Turnaround Success

Summary 3M has shown signs of a turnaround with a doubling stock price since October 2023, but operational top line growth remains modest, justifying a "hold" rating. The company expects modest organic revenue growth of 2-3% in 2025, driven by innovations and new product launches, but analysts are less optimistic. Current valuation is high with a forward P/E ratio above the five-year median, limiting upside potential amid risks like trade disputes and economic slowdowns. Read the full article on Seeking Alpha
Seeking Alpha • Feb 07

3M: More Upside Ahead - But Wait For A Moderate Retracement

Summary MMM's reversal is already here, thanks to the SOLV divestiture bringing forth a more focused portfolio and healthier balance sheet. This is on top of the resolution of its legal headwinds, as management also pursues insurance recovery and $340M already completed. The management has driven new growth opportunities through its legacy businesses and new product launches as well, despite certain market softness. These reasons are likely why the market has upgraded MMM's valuations and the investors have defended the stock's uptrend support line thus far. With double digit capital appreciation prospects, we are reiterating our Buy rating here with one caveat. We shall further discuss. Read the full article on Seeking Alpha
Seeking Alpha • Jan 23

3M Is Structurally Shifting For Durable Growth

Summary 3M's focus on innovation and operational improvements under CEO Bill Brown may lead to significant top-line growth and margin expansion. Management is aiming to enhance supply chain efficiencies and increasing production launches while improving the firm's on-time, in-full deliveries. 3M has a substantial amount of inventory that may be worked down in the coming quarters, potentially acting as a tailwind for free cash flow generation in the coming years. Read the full article on Seeking Alpha
Seeking Alpha • Jan 06

Downgrading 3M Due To Persistent Litigation Risks And Stagnant Sales Growth

Summary I am downgrading 3M from hold to sell due to slow revenue growth, ongoing litigation risks, and inflated stock valuation despite recent gains. Revenue growth is expected to underpace inflation, driven by product line adjustments, declining European demand, and the healthcare spin-off. Despite settling some litigations, 3M faces significant pending lawsuits, posing substantial financial risks. Shares appear expensive when accounting for slow growth and litigation risks, with a fair value estimate of $86 per share, 34% below current trading. Read the full article on Seeking Alpha
Seeking Alpha • Dec 30

One Of JPMorgan's Value Picks For 2025, 3M Could Have A Bright Year Ahead

Summary JPMorgan highlights 3M Company as a key investment idea for 2025, despite ongoing legal challenges and growth issues, leading to my Hold rating. 3M's diverse operations span Safety & Industrial, Transportation & Electronics, Consumer, and Healthcare, with a strong focus on innovation and high-margin products. The company reported 1% organic growth and an 18% rise in adjusted EPS for Q3 2024, showcasing operational efficiency and cost management. With a healthy 23% margin and $1.5 billion free cash flow, MMM balances rewarding shareholders with investing in growth initiatives. Read the full article on Seeking Alpha
Seeking Alpha • Nov 25

3M: Seems A Bit Too Expensive Considering The Slow Growth

Summary Earlier this year, CEO William Brown said 3M's products are aging. Now and in the near future, it seems like the company is focussing on new products and research. It seems like the uncertainty-creating lawsuits are now largely settled, but the costs will weigh on the company for several years to come. Nevertheless, 3M has a strong financial position and rewards its shareholders with dividends and buybacks, but I'm waiting because I believe it is slightly too expensive. Read the full article on Seeking Alpha

業績と収益の成長予測

NYSE:MMM - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202827,4285,0894,2445,9728
12/31/202726,4884,8524,3725,20814
12/31/202625,4013,9603,2795,06714
6/30/202625,1802,9973,9854,899N/A
3/31/202625,0242,7872,0602,959N/A
12/31/202524,9483,2501,3962,306N/A
9/30/202524,8253,4011,5882,541N/A
6/30/202524,6023,939-1,983-1,002N/A
3/31/202524,5134,420-69973N/A
12/31/202424,5754,0096381,819N/A
9/30/202424,5673,9157391,987N/A
6/30/202424,543164,2775,684N/A
3/31/202424,571-8,3594,6576,172N/A
12/31/202324,610-8,4025,0656,680N/A
9/30/202326,687-8,4954,8536,616N/A
6/30/202329,036-2,1094,4446,237N/A
3/31/202331,4555,1404,0555,855N/A
12/31/202226,1614,0133,8425,591N/A
9/30/202234,7626,5753,8755,674N/A
6/30/202235,0854,1504,3106,017N/A
3/31/202235,3335,5965,0606,777N/A
12/31/202135,3555,9215,8517,454N/A
9/30/202135,3265,9876,4957,964N/A
6/30/202134,7345,9837,0768,570N/A
3/31/202132,9605,7657,1098,588N/A
12/31/202032,1845,4496,6128,113N/A
9/30/202031,7125,0136,3197,936N/A
6/30/202031,3535,1665,8807,478N/A
3/31/202032,3484,987N/A7,235N/A
12/31/201932,1364,517N/A7,070N/A
9/30/201931,9704,948N/A6,990N/A
6/30/201932,1314,908N/A7,107N/A
3/31/201932,3505,638N/A7,344N/A
12/31/201832,7655,349N/A6,439N/A
9/30/201832,8104,525N/A6,041N/A
6/30/201832,8304,411N/A5,652N/A
3/31/201832,2504,137N/A5,395N/A
12/31/201731,6574,858N/A6,240N/A
9/30/201730,9965,490N/A6,589N/A
6/30/201730,5335,390N/A6,747N/A
3/31/201730,3855,098N/A6,390N/A
12/31/201630,1095,050N/A6,662N/A
9/30/201630,0784,933N/A6,791N/A
6/30/201630,0814,900N/A6,547N/A
3/31/201630,1054,909N/A6,600N/A
12/31/201530,2744,833N/A6,420N/A
9/30/201530,6954,974N/A6,265N/A

アナリストによる今後の成長予測

収入対貯蓄率: MMMの予測収益成長率 (年間12.1% ) は 貯蓄率 ( 3.7% ) を上回っています。

収益対市場: MMMの収益 ( 12.1% ) US市場 ( 16.8% ) よりも低い成長が予測されています。

高成長収益: MMMの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: MMMの収益 ( 3.2% ) US市場 ( 12.9% ) よりも低い成長が予測されています。

高い収益成長: MMMの収益 ( 3.2% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: MMMの 自己資本利益率 は、3年後には非常に高くなると予測されています ( 74 %)。

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/08/11 22:26
終値2026/08/11 00:00
収益2026/06/30
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

3M Company 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。29

アナリスト機関
John EadeArgus Research Company
Julian MitchellBarclays
Robert CornellBarclays